Atypical Teratoid/Rhabdoid Tumor
AT/RT (atypical teratoid/rhabdoid tumor) is an aggressive CNS WHO grade 4 pediatric tumor defined by SMARCB1 biallelic LOF (~95%) or SMARCA4 LOF (~5%); peak <3 years; three molecular subgroups (TYR, SHH, MYC); multimodal therapy; 2-year OS ~40-50%; germline SMARCB1 → RTPS1.
Entry Metadata
| Field | Value |
|---|---|
| ID | atypical-teratoid-rhabdoid-tumor |
| Name | Atypical Teratoid/Rhabdoid Tumor |
| Status | draft |
| Last reviewed | 2026-06-06 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59(1):74-79. · PubMed 9892189
- Frühwald MC, Hasselblatt M, Nemes K, et al. Age and DNA methylation subgroup as potential treatment targets in children with atypical teratoid rhabdoid tumors. Neuro Oncol. 2020;22(7):1006-1017. · PubMed 31900478